The stock carries a Zacks Rank #3 (Hold). Tandem Diabetes is driving transformative innovation to help reduce the burden and create new possibilities for people living with diabetes.

Tandem Diabetes Care launched a new predictive feature designed to help reduce the frequency and duration of low-glucose events by pausing insulin delivery.

Tandem Diabetes Care to offer no-cost feature updates for t:slim X2 insulin pump customers in the US through the end of 2020.

Tandem undertakes no obligation to update or review any forward-looking statement in this press release because of new information, future events or other factors. ©2025 Tandem Diabetes Care, Inc.

Tandem Diabetes Care’s Control-IQ artificial pancreas system also includes the agency’s first interoperable automated dosing controller, making it capable of connecting with different ...

Tandem takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin.

DiabetesMine reports on business and product updates from Tandem Diabetes Care, shared around the big ADA Scientific Sessions event in early June 2017.

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around ...

Tandem Diabetes is driving transformative innovation to help reduce the burden and create new possibilities for people living with diabetes. During the second quarter, its flagship t:slim X2 ...